PMID- 37460830 OWN - NLM STAT- MEDLINE DCOM- 20230911 LR - 20231221 IS - 1128-045X (Electronic) IS - 1123-6337 (Print) IS - 1123-6337 (Linking) VI - 27 IP - 10 DP - 2023 Oct TI - Efficacy of different surgical treatments for management of anal fistula: a network meta-analysis. PG - 827-845 LID - 10.1007/s10151-023-02845-8 [doi] AB - PURPOSE: Currently, the anal fistula treatment which optimises healing and preserves bowel continence remains unclear. The aim of our study was to compare the relative efficacy of different surgical treatments for AF through a network meta-analysis. METHODS: Systematic searches of MEDLINE, EMBASE and CENTRAL databases up to October 2022 identified randomised controlled trials (RCTs) comparing surgical treatments for anal fistulae. Fistulae were classified as simple (inter-sphincteric or low trans-sphincteric fistulae crossing less than 30% of the external anal sphincter (EAS)) and complex (high trans-sphincteric fistulae involving more than 30% of the EAS). Treatments evaluated in only one trial were excluded from the primary analyses to minimise bias. The primary outcomes were rates of success in achieving AF healing and bowel incontinence. RESULTS: Fifty-two RCTs were included. Of the 14 treatments considered, there were no significant differences regarding short-term (6 months or less postoperatively) and long-term (more than 6 months postoperatively) success rates between any of the treatments in patients with both simple and complex anal fistula. Ligation of the inter-sphincteric fistula tract (LIFT) ranked best for minimising bowel incontinence in simple (99.1% of comparisons; 3 trials, n = 70 patients) and complex anal fistula (86.2% of comparisons; 3 trials, n = 102 patients). CONCLUSIONS: There is insufficient evidence in existing RCTs to recommend one treatment over another regarding their short and long-term efficacy in successfully facilitating healing of both simple and complex anal fistulae. However, LIFT appears to be associated with the least impairment of bowel continence, irrespective of AF classification. CI - (c) 2023. The Author(s). FAU - Bhat, S AU - Bhat S AUID- ORCID: 0000-0003-3770-8996 AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. AD - Department of Surgery, Te Whatu Ora MidCentral, Palmerston North, New Zealand. FAU - Xu, W AU - Xu W AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. AD - Department of Surgery, Te Whatu Ora Te Toka Tumai, Whangarei, New Zealand. FAU - Varghese, C AU - Varghese C AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. FAU - Dubey, N AU - Dubey N AD - Department of General Medicine, Tauranga Hospital, Te Whatu Ora, Tauranga, New Zealand. FAU - Wells, C I AU - Wells CI AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. AD - Department of Surgery, Te Whatu Ora Te Toka Tumai, Auckland, New Zealand. FAU - Harmston, C AU - Harmston C AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. AD - Department of Surgery, Te Whatu Ora Te Toka Tumai, Whangarei, New Zealand. FAU - O'Grady, G AU - O'Grady G AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. AD - Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand. FAU - Bissett, I P AU - Bissett IP AD - Surgical and Translational Research Centre, Department of Surgery, The University of Auckland, Auckland, New Zealand. FAU - Lin, A Y AU - Lin AY AD - Department of Surgery and Anaesthesia, University of Otago, Wellington, New Zealand. tony.lin@otago.ac.nz. AD - Department of Surgery, Wellington Regional Hospital, Te Whatu Ora, Wellington, New Zealand. tony.lin@otago.ac.nz. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review DEP - 20230717 PL - Italy TA - Tech Coloproctol JT - Techniques in coloproctology JID - 9613614 SB - IM MH - Humans MH - *Fecal Incontinence/etiology/surgery MH - Network Meta-Analysis MH - Wound Healing MH - Anal Canal/surgery MH - Ligation/adverse effects MH - *Rectal Fistula/surgery/etiology MH - Treatment Outcome PMC - PMC10485107 OTO - NOTNLM OT - Complex OT - Fistula-in-ano OT - Healing OT - Incontinence OT - Sphincter preserving COIS- Professor Greg O'Grady and Professor Ian P. Bissett have ownership interests with The Insides Company Ltd (Auckland, New Zealand). Professor O'Grady is an executive director, co-founder, and chief scientific officer. Professor Bissett is a co-founder and chief medical officer. Professor O'Grady is also a co-founder and chief executive officer of Alimetry Ltd (Auckland, New Zealand). The remaining authors have no conflicts of interest to disclose. EDAT- 2023/07/18 01:09 MHDA- 2023/09/11 06:43 PMCR- 2023/07/17 CRDT- 2023/07/17 23:34 PHST- 2023/05/03 00:00 [received] PHST- 2023/07/06 00:00 [accepted] PHST- 2023/09/11 06:43 [medline] PHST- 2023/07/18 01:09 [pubmed] PHST- 2023/07/17 23:34 [entrez] PHST- 2023/07/17 00:00 [pmc-release] AID - 10.1007/s10151-023-02845-8 [pii] AID - 2845 [pii] AID - 10.1007/s10151-023-02845-8 [doi] PST - ppublish SO - Tech Coloproctol. 2023 Oct;27(10):827-845. doi: 10.1007/s10151-023-02845-8. Epub 2023 Jul 17.